Two Newly Isolated Enterobacter-Specific Bacteriophages: Biological Properties and Stability Studies
暂无分享,去创建一个
[1] S. Brisse,et al. In Vitro and In Vivo Assessments of Two Newly Isolated Bacteriophages against an ST13 Urinary Tract Infection Klebsiella pneumoniae , 2022, Viruses.
[2] Ionela-Larisa Miftode,et al. What Doesn’t Kill Them Makes Them Stronger: The Impact of the Resistance Patterns of Urinary Enterobacterales Isolates in Patients from a Tertiary Hospital in Eastern Europe , 2022, Antibiotics.
[3] D. Van Tyne,et al. Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates , 2022, PHAGE.
[4] Robin Patel,et al. Considerations for the Use of Phage Therapy in Clinical Practice , 2022, Antimicrobial agents and chemotherapy.
[5] Lijuan Yuan,et al. Comparision of biological and genomic characteristics of five virulent bacteriophages against Enterobacter hormaechei. , 2021, Microbial pathogenesis.
[6] Michaela Corina Crisan,et al. Copper Nanoparticles: Synthesis and Characterization, Physiology, Toxicity and Antimicrobial Applications , 2021, Applied Sciences.
[7] A. Nair,et al. Characterization of a novel, biofilm dispersing, lytic bacteriophage against drug‐resistant Enterobacter cloacae , 2021, Journal of applied microbiology.
[8] Evelien M. Adriaenssens,et al. Phage Annotation Guide: Guidelines for Assembly and High-Quality Annotation , 2021, PHAGE.
[9] S. Brenner,et al. Nanotechnology Fundamentals Applied to Clinical Infectious Diseases and Public Health , 2021, Open forum infectious diseases.
[10] Michał Wójcicki,et al. Characterization and Genome Study of Novel Lytic Bacteriophages against Prevailing Saprophytic Bacterial Microflora of Minimally Processed Plant-Based Food Products , 2021, International journal of molecular sciences.
[11] F. Stellacci,et al. Broad-spectrum nanoparticles against bacteriophage infections , 2021, Nanoscale.
[12] K. Hulten,et al. Risk factors for microbiologic failure in children with Enterobacter species bacteremia , 2021, PloS one.
[13] A. Maresso,et al. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection , 2021, Viruses.
[14] S. S. Giri,et al. The Characterization of a Novel Phage, pPa_SNUABM_DT01, Infecting Pseudomonas aeruginosa , 2021, Microorganisms.
[15] Charles E. Grant,et al. XSTREME: Comprehensive motif analysis of biological sequence datasets , 2021, bioRxiv.
[16] S. Kakou-ngazoa,et al. Investigation of Phages Infecting Escherichia coli Strains B and C, and Enterobacter cloacae in Sewage and Ebrié Lagoon, Côte d'Ivoire. , 2021, PHAGE.
[17] Ying Zhang,et al. Molecular Mechanisms and Epidemiology of Carbapenem-Resistant Enterobacter cloacae Complex Isolated from Chinese Patients During 2004–2018 , 2021, Infection and drug resistance.
[18] K. Peck,et al. Difference in the Clinical Outcome of Bloodstream Infections Caused by Klebsiella aerogenes and Enterobacter cloacae Complex , 2021, Open forum infectious diseases.
[19] M. Castanheira,et al. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection , 2021, JAC-antimicrobial resistance.
[20] N. Tikunova,et al. A New Enterobacter cloacae Bacteriophage EC151 Encodes the Deazaguanine DNA Modification Pathway and Represents a New Genus within the Siphoviridae Family , 2021, Viruses.
[21] Abdallah S. Abdelsattar,et al. The Synergistic Effect of Biosynthesized Silver Nanoparticles and Phage ZCSE2 as a Novel Approach to Combat Multidrug-Resistant Salmonella enterica , 2021, Antibiotics.
[22] S. Rutjes,et al. Surface chemistry-dependent antiviral activity of silver nanoparticles , 2021, Nanotechnology.
[23] J. Rodríguez-Baño,et al. Clinical characteristics and outcome of bacteremia caused by Enterobacter cloacae and Klebsiella aerogenes: more similarities than differences. , 2021, Journal of global antimicrobial resistance.
[24] S. Réhman,et al. Characterization of a lytic EBP bacteriophage with large size genome against Enterobacter cloacae , 2021, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[25] M. Vaneechoutte,et al. Evaluation of the Stability of Bacteriophages in Different Solutions Suitable for the Production of Magistral Preparations in Belgium , 2021, Viruses.
[26] A. Shariati,et al. Bacteriophage therapy for inhibition of multi drug‐resistant uropathogenic bacteria: a narrative review , 2021, Annals of clinical microbiology and antimicrobials.
[27] Martha R. J. Clokie,et al. Preclinical data and safety assessment of phage therapy in humans , 2021, Current opinion in biotechnology.
[28] V. Voliani,et al. Antimicrobial Nano-Agents: The Copper Age , 2021, ACS nano.
[29] Evelien M. Adriaenssens,et al. A Roadmap for Genome-Based Phage Taxonomy , 2021, Viruses.
[30] Brahma N. Singh,et al. Chrysophanol-Functionalized Silver Nanoparticles for Anti-Adhesive and Anti-Biofouling Coatings to Prevent Urinary Catheter-Associated Infections , 2021 .
[31] G. Węgrzyn,et al. Phage–Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against Enterococcus faecalis , 2021, Viruses.
[32] Qin Hu,et al. Isolation and genomic characterization of P.A-5, a novel virulent bacteriophage against Enterobacter hormaechei. , 2021, Microbial pathogenesis.
[33] Junxing Yang,et al. Enterobacter cloacae infection of the shoulder in a 52-year-old woman without apparent predisposing risk factor: a case report and literature review , 2021, BMC Infectious Diseases.
[34] Narmada Thanki,et al. RefSeq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation , 2020, Nucleic Acids Res..
[35] Ying Zhang,et al. Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin , 2020, BMC Microbiology.
[36] J. Borysowski,et al. Phage Therapy: Towards a Successful Clinical Trial , 2020, Antibiotics.
[37] N. Ács,et al. Bacteriophage Enumeration and Detection Methods , 2020, Frontiers in Microbiology.
[38] F. Vandenesch,et al. Enterobacter cloacae colonisation and infection in a neonatal intensive care unit: retrospective investigation of preventive measures implemented after a multiclonal outbreak , 2020, BMC Infectious Diseases.
[39] T. Kessler,et al. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. , 2020, The Lancet. Infectious diseases.
[40] T. G. Villa,et al. Bacteriophages and Lysins as Possible Alternatives to Treat Antibiotic-Resistant Urinary Tract Infections , 2020, Antibiotics.
[41] A. Okoh,et al. Enterobacter cloacae harbouring blaNDM-1, blaKPC , and blaOXA-48-like carbapenem-resistant genes isolated from different environmental sources in South Africa , 2020 .
[42] Xiaoyu Li,et al. Genome sequence analysis of a novel Enterobacter cloacae phage, Ec_L1, belonging to the genus Eclunavirus , 2020, Archives of Virology.
[43] G. Sutton,et al. Newly Named Klebsiella aerogenes (formerly Enterobacter aerogenes) Is Associated with Poor Clinical Outcomes Relative to Other Enterobacter Species in Patients with Bloodstream Infection , 2020, Journal of Clinical Microbiology.
[44] Jessica Pourraz,et al. Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures , 2020, Palgrave Communications.
[45] H. Wei,et al. Application of Adaptive Evolution to Improve the Stability of Bacteriophages during Storage , 2020, Viruses.
[46] D. A. Court,et al. Characterization of the Enterobacter Phage vB_EclM_CIP9 , 2020, Microbiology Resource Announcements.
[47] G. Węgrzyn,et al. Characterization of a bacteriophage, vB_Eco4M-7, that effectively infects many Escherichia coli O157 strains , 2020, Scientific Reports.
[48] Chao-Min Cheng,et al. Role of pH Value in Clinically Relevant Diagnosis , 2020, Diagnostics.
[49] Lu Sun,et al. NCBI Taxonomy: a comprehensive update on curation, resources and tools , 2020, Database J. Biol. Databases Curation.
[50] F. Tay,et al. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections , 2019, Advanced science.
[51] Geoffrey L. Winsor,et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database , 2019, Nucleic Acids Res..
[52] V. Mlambo,et al. Characterization of Lytic Bacteriophages Infecting Multidrug-Resistant Shiga Toxigenic Atypical Escherichia coli O177 Strains Isolated From Cattle Feces , 2019, Front. Public Health.
[53] A. Maresso,et al. Constructing and Characterizing Bacteriophage Libraries for Phage Therapy of Human Infections , 2019, Front. Microbiol..
[54] B. Verhasselt,et al. A recurrent and transesophageal echocardiography–associated outbreak of extended-spectrum β-lactamase–producing Enterobacter cloacae complex in cardiac surgery patients , 2019, Antimicrobial Resistance & Infection Control.
[55] Shikha Malik,et al. Managing urinary tract infections through phage therapy: a novel approach , 2019, Folia Microbiologica.
[56] O. Bajolet,et al. Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone-cotrimoxazole combination. , 2019, International journal of antimicrobial agents.
[57] M. Blanco,et al. Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients , 2019, Scientific Reports.
[58] P. Rossmanith,et al. Don’t Shut the Stable Door after the Phage Has Bolted—The Importance of Bacteriophage Inactivation in Food Environments , 2019, Viruses.
[59] T. Maerken,et al. Nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae among cardiothoracic surgical patients: causes and consequences. , 2019, The Journal of hospital infection.
[60] K. Pardesi,et al. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review , 2019, Front. Microbiol..
[61] C. Lundborg,et al. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species , 2019, Front. Microbiol..
[62] Jing Yuan,et al. Characterizing the Biology of Lytic Bacteriophage vB_EaeM_φEap-3 Infecting Multidrug-Resistant Enterobacter aerogenes , 2019, Front. Microbiol..
[63] P. Hyman. Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth , 2019, Pharmaceuticals.
[64] Dejenie Shiferaw Teklu,et al. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia , 2019, Antimicrobial Resistance & Infection Control.
[65] A. Uhlemann,et al. Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat , 2019, Front. Microbiol..
[66] G. Węgrzyn,et al. Characterization of Bacteriophage vB-EcoS-95, Isolated From Urban Sewage and Revealing Extremely Rapid Lytic Development , 2019, Front. Microbiol..
[67] R. Blasco,et al. Study of pH Changes in Media during Bacterial Growth of Several Environmental Strains , 2018, Proceedings.
[68] Muhammad Imran,et al. Isolation, characterization and efficacy of phage MJ2 against biofilm forming multi-drug resistant Enterobacter cloacae , 2018, Folia Microbiologica.
[69] D. Isaacs,et al. Enterobacter cloacae osteoarticular infection without risk factors: Case report and review of the literature , 2018, Journal of paediatrics and child health.
[70] V. Aquili,et al. Resistance of phages lytic to pathogenic Escherichia coli to sanitisers used by the food industry and in home settings , 2018 .
[71] Wen J. Li,et al. RefSeq: an update on prokaryotic genome annotation and curation , 2017, Nucleic Acids Res..
[72] Elliot J. Lefkowitz,et al. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV) , 2017, Nucleic Acids Res..
[73] E. Mylonakis,et al. Urinary tract infections caused by ESBL‐producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta‐analysis , 2017, Transplant infectious disease : an official journal of the Transplantation Society.
[74] T. Kessler,et al. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial , 2017, BMC Urology.
[75] P. Hyman,et al. More Is Better: Selecting for Broad Host Range Bacteriophages , 2016, Front. Microbiol..
[76] S. Abedon. Phage therapy dosing: The problem(s) with multiplicity of infection (MOI) , 2016, Bacteriophage.
[77] Eric P. Nawrocki,et al. NCBI prokaryotic genome annotation pipeline , 2016, Nucleic acids research.
[78] Jing Yuan,et al. Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes , 2016, Scientific Reports.
[79] N. Indrawattana,et al. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens , 2016, BioMed research international.
[80] R. Zbinden,et al. Bacteriophages as Potential Treatment for Urinary Tract Infections , 2016, Front. Microbiol..
[81] Dmitry Antipov,et al. hybridSPAdes: an algorithm for hybrid assembly of short and long reads , 2016, Bioinform..
[82] Nelson Durán,et al. Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[83] J. Klumpp,et al. Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples. , 2016, Virus research.
[84] B. Bakhshi,et al. Particular Distribution of Enterobacter cloacae Strains Isolated from Urinary Tract Infection within Clonal Complexes , 2016, Iranian biomedical journal.
[85] S. Réhman,et al. Isolation and characterization of lytic phages TSE1-3 against Enterobacter cloacae , 2016 .
[86] Andrey D. Prjibelski,et al. Assembling short reads from jumping libraries with large insert sizes , 2015, Bioinform..
[87] Roshmi Thomas,et al. Inhibitory effect of silver nanoparticle fabricated urinary catheter on colonization efficiency of Coagulase Negative Staphylococci. , 2015, Journal of photochemistry and photobiology. B, Biology.
[88] N. Fierer,et al. The Evolution of Stomach Acidity and Its Relevance to the Human Microbiome , 2015, PloS one.
[89] F. Şahin,et al. Enterobacter Strains Might Promote Colon Cancer , 2015, Current Microbiology.
[90] M. Osthoff,et al. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[91] Xiaosheng Ma,et al. Enterobacter cloacae infection after anterior cervical decompression and fusion: case study and literature review. , 2015, International journal of clinical and experimental medicine.
[92] Torsten Seemann,et al. Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..
[93] Alla Lapidus,et al. ExSPAnder: a universal repeat resolver for DNA fragment assembly , 2014, Bioinform..
[94] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[95] Andrea Pinna,et al. Orione, a web-based framework for NGS analysis in microbiology , 2014, Bioinform..
[96] I. Goic-Barisic,et al. Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia. , 2014, Microbial drug resistance.
[97] Kamaljit Singh,et al. Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department , 2013, Emergency medicine international.
[98] Dmitry Antipov,et al. Assembling Genomes and Mini-metagenomes from Highly Chimeric Reads , 2013, RECOMB.
[99] Sergey I. Nikolenko,et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..
[100] Shane S. Sturrock,et al. Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..
[101] H. Ackermann. Bacteriophage electron microscopy. , 2012, Advances in virus research.
[102] J. Ayala,et al. Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. , 2011, The Journal of antimicrobial chemotherapy.
[103] A. Górski,et al. The influence of external factors on bacteriophages—review , 2011, Folia Microbiologica.
[104] T. Dean,et al. Enumeration of bacteriophage particles , 2011, Bacteriophage.
[105] C. Prudêncio,et al. Post‐surgical wound infections involving Enterobacteriaceae with reduced susceptibility to β‐lactams in two Portuguese hospitals , 2010, International wound journal.
[106] N. Perna,et al. progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement , 2010, PloS one.
[107] A. Kropinski. Measurement of the rate of attachment of bacteriophage to cells. , 2009, Methods in molecular biology.
[108] E. Lingohr,et al. Enumeration of bacteriophages by double agar overlay plaque assay. , 2009, Methods in molecular biology.
[109] L. Rice. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. , 2008, The Journal of infectious diseases.
[110] B. Gibbins,et al. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.
[111] M. Kaufmann,et al. An outbreak of wound infection in cardiac surgery patients caused by Enterobacter cloacae arising from cardioplegia ice. , 2006, Journal of Hospital Infection.
[112] B. Cunha,et al. Enterobacter cloacae graft infection/bacteremia in a hemodialysis patient. , 2000, American journal of infection control.
[113] M. Dabrowski,et al. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. , 1984, Archivum immunologiae et therapiae experimentalis.
[114] P. R. Edwards,et al. A Proposed Genus Enterobacter , 1960 .